— Know what they know.
Not Investment Advice

CTE.AX ASX

Cryosite Limited
1W: -1.7% 1M: -8.0% 3M: -8.0% YTD: -5.0% 1Y: +43.8% 3Y: +102.1% 5Y: +195.6%
A$1.15 ($0.80)
+0.00 (+0.00%)
 
ASX · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 42 · A$56.1M mcap · 7M float · 0.048% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market CapA$56.1M ($39.0M)
52W Range0.84-1.4
Volume10,117
Avg Volume3,252
Beta0.16
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJane Hao
Employees27
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2002-05-09
13a Ferndell Street
South Granville, NSW 2142
AU
61 2 8865 2000
About Cryosite Limited

Cryosite Limited, founded in 1999 and headquartered in South Granville, Australia, specializes in providing outsourced logistics and storage solutions to the life sciences industry within Australia. The company operates through two distinct divisions. Its Clinical Trials and Biological Services Logistics segment offers comprehensive support to the clinical research and pharmaceutical sectors, encompassing services such as specialized temperature-controlled and general biological storage, precise labeling, secondary packaging, and end-to-end supply chain management capabilities like scheduled drug distribution, returns processing, material destruction, status oversight, comparator sourcing, and validated import/export and transportation. The second division, Cord Blood and Tissues Storage, focuses on the long-term cryogenic preservation of cord blood and tissue samples. Cryosite's client base spans the research, medical, pharmaceutical, veterinary, and biotechnology industries.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms